Ovid Therapeutics (OVID) P/E (2017 - 2026)
Ovid Therapeutics (OVID) P/E from May 5, 2017 to Jul 21, 2026. The TTM Ovid Therapeutics (OVID) P/E is -17.53. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Ovid Therapeutics (OVID)
| Year | P/E | Change |
|---|---|---|
| 2026 | -17.53 | +10.57% |
| 2025 | -15.86 | +194.33% |
| 2024 | -5.39 | -46.49% |
| 2023 | -10.07 | +145.54% |
| 2022 | -4.10 | -208.53% |
| 2021 | 3.78 | -203.05% |
| 2020 | -3.67 | -40.50% |
| 2019 | -6.16 | +149.81% |
| 2018 | -2.47 | -31.09% |
| 2017 | -3.58 | N/A |
Comparison Ovid Therapeutics (OVID) P/E with competitors
Ovid Therapeutics (OVID) P/E is -17.53.